Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA.
Division of Gastroenterology, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
Gut Liver. 2022 Jul 15;16(4):503-514. doi: 10.5009/gnl210224. Epub 2021 Oct 25.
has been well known to cause gastritis, peptic ulcers, mucosa-associated lymphoid tissue, and gastric cancer. The importance of eradication has been emphasized; however, the management of infection is difficult in clinical practice. In both Eastern and Western countries, there has been a constant interest in confirming individuals who should be tested and treated for infection and developing methods to diagnose infection. Many studies have been implemented to successfully eradicate , and various combinations of eradication regimens for infection have been suggested worldwide. Based on the findings of previous studies, a few countries have published their own guidelines that are appropriate for their country; however, these country-specific guidelines may differ depending on the circumstances in each country. Evidence-based guidelines and clinical practice updates for the treatment of infection have been published in Korea and the United States in 2021. This review will summarize the similarities and differences in the management of infection in Korea and the United States, focusing on indications, diagnosis, and treatments based on recent guidelines and recommendations in both countries.
已被充分证实可导致胃炎、消化性溃疡、黏膜相关淋巴组织和胃癌。根除的重要性已得到强调;然而,在临床实践中,感染的管理具有一定难度。在东方和西方国家,人们一直关注确定应接受检测和治疗的个体以及开发用于诊断感染的方法。已经实施了许多研究来成功根除[Helicobacter pylori],并且已经在全球范围内提出了多种用于[Helicobacter pylori]感染的根除方案组合。基于之前研究的结果,一些国家已经发布了适合本国国情的指南;然而,这些特定于国家的指南可能因各国的具体情况而有所不同。2021 年,韩国和美国发布了针对[Helicobacter pylori]感染治疗的循证指南和临床实践更新。本综述将总结韩国和美国在[Helicobacter pylori]感染管理方面的异同,重点关注两国最近的指南和建议中基于的适应证、诊断和治疗。